As per our research report, the size of the global diagnostic imaging market was worth USD 38.34 billion in 2023. The global diagnostic imaging market is estimated to be growing at a CAGR of 6.67% from 2024 to 2032 and be worth USD 68.55 billion by 2032 from USD 40.9 billion in 2024.
Diagnostic imaging is also called medical imaging. Medical imaging depicts information and picturization of internal organs and abnormalities. It establishes a database for anatomy and physiology to make it easy to identify abnormalities. Medical imaging draws images or visual representations of various parts of the human body with digital health to diagnose and treat underlying diseases.
Then, any other market considering the healthcare sector's diagnostic imaging market holds the most considerable revenue and will continue to grow due to technological advancements, rising incidences of chronic diseases, awareness in the population of a healthy lifestyle, and early detection of diseases. R&D activities are a key factor for market growth. Government funding to healthcare sectors and, most importantly, the diagnostic imaging market is crucial for growth. In developing regions such as Asia-Pacific and LAMEA, the market is expected to grow immensely. Highly populated countries where the senior population's ratio is high also hold the most significant shares globally.
Government initiatives to create awareness of the early stages of diagnosis and treatment and investments from government and private organizations to worldwide healthcare fuel the diagnostic imaging market. Technological advances in the diagnostic imaging market led to new inventions, such as devices for various disease diagnoses. In addition, the rising demand for providing knowledge to students in hospitals and universities by providing training for advanced medical imaging technology influences the market growth. With an increase in population and chronic diseases such as diabetes, cancers, cardiovascular issues, and organ failures, the spread of diseases and infections is expected to increase market size.
Various health monitoring systems introduced by the government, easy usage of mobile health systems, subscription plans in healthcare apps, and a rise in vulnerable diseases augment market growth factors. In addition, the rise in demand for various medical diagnostic tests such as MRI, nuclear imaging and PET scans, Ultrasound, Computed Tomography (CT) scans, and X-rays are the primary growth contributing factors for the diagnostic imaging market across the globe.
The preliminary reimbursement plans, high costs associated with diagnosis plans and procedures, and helium shortage are expected to hamper the market growth. Skilled workers are needed daily. Since this market lacks skilled workers and staff, operating all the procedures will cause low market growth. In addition, the risk of radiation exposure is high for patients, workers, and staff; this may create significant health issues with daily exposure. Recently, a severe helium shortage has been recorded in many countries, and stringent approval regulations restricted this market. In addition, repeated quality checks and control of medical devices are hard to process.
REPORT METRIC |
DETAILS |
Market Size Available |
2023 to 2032 |
Base Year |
2023 |
Forecast Period |
2024 to 2032 |
Segments Covered |
By Type, Application and Region |
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges; PESTLE Analysis; Porter's Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities |
Regions Covered |
North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa |
Key Market Players |
GE Healthcare, Siemens Healthcare, Toshiba Medical Systems Corporation, Hitachi Medical Corporation, Hologic Inc., and Fujifilm Shimadzu Corporation |
The ultrasound segment had the largest worldwide market share in 2023 and the segment’s domination is expected to continue during the forecast period owing to the growing number of cancer patients.
On the other hand, the CT scan segment held the second-largest share in the global diagnostic imaging market in 2022. The use of AI in the CT scan has improved image quality. The CT scan has contributed notably to oncology, neurology, and cardiology. The CT scan segment is widely used as it increases cancer discovery chances and decreases the patient's cases for further tests.
The diagnostic imaging market in North America had the major share of the worldwide market in 2023 and is anticipated to continue holding a significant share of the global market during the forecast period, owing to the growing healthcare spending. Nearly 20% of the GDP is spent on healthcare in the USA. An increasing number of patients with chronic diseases fuel the region's growth rate. In addition, the adoption of technological advancements in imaging technologies favors regional market growth. Furthermore, the presence of more key players and contributors is an augmenting factor for market growth.
The European market is expected to grow substantially during the forecast period due to its rising geriatric and pediatric population ratio.
However, the Asia-Pacific region is projected to grow at the highest CAGR during the forecast period due to a rapidly aging populace and a surge in the chronic disease population. Japan is the biggest diagnostic market in the Asia Pacific region. In addition, the emergence of advanced technology and the launch of innovative products bolstered the market's demand. Therefore, the Asia Pacific is expected to showcase the highest rise throughout the forecast period. Due to the highest population and disease ratio in countries like India, China, and Japan, the market expects the highest growth. South Korea's market has a massive manufacturing and production system.
The Latin American market is anticipated to hold a considerable share of the worldwide market during the forecast period. The diagnostic imaging market in MEA is forecasted to grow at a moderate CAGR in the coming years.
Some of the notable companies dominating the global diagnostic imaging market profiled in this report are GE Healthcare, Siemens Healthcare, Toshiba Medical Systems Corporation, Hitachi Medical Corporation, Hologic Inc., and Fujifilm Shimadzu Corporation.
By Type
By Application
By Region
Frequently Asked Questions
The global diagnostic/medical Imaging market size was valued at USD 40.90 billion in 2024.
Geographically, the North American diagnostic/medical Imaging market accounted for the largest share of the global market in 2023.
The diagnostic/medical Imaging market is estimated to grow at a CAGR of 6.67% from 2023 to 2032.
Yes, we have studied and included the COVID-19 impact on the global diagnostic/medical Imaging market in this report.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region